Drugs / Ezetimibe/atorvastatin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01370590 | Sep 2011 → Apr 2012 | hyperlipidemia | Organon and Co | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ezetimibe/atorvastatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01370590 ↗ |
| Route | Oral | “Ezetimibe/atorvastatin 10 mg/20 mg combination tablet administered orally once daily” NCT01370590 ↗ |